Cargando…

Chenodeoxycholic Acid Reduces Hypoxia Inducible Factor-1α Protein and Its Target Genes

This study evaluated HIF-1α inhibitors under different hypoxic conditions, physiological hypoxia (5% O(2)) and severe hypoxia (0.1% O(2)). We found that chenodeoxy cholic acid (CDCA) reduced the amount of HIF-1α protein only under physiological hypoxia but not under severe hypoxia without decreasing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moon, Yunwon, Choi, Su Mi, Chang, Soojeong, Park, Bongju, Lee, Seongyeol, Lee, Mi-Ock, Choi, Hueng-Sik, Park, Hyunsung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476666/ https://www.ncbi.nlm.nih.gov/pubmed/26098428 http://dx.doi.org/10.1371/journal.pone.0130911

Ejemplares similares

HIF-1α-Dependent Induction of Carboxypeptidase A4 and Carboxypeptidase E in Hypoxic Human Adipose-Derived Stem Cells
por: Moon, Yunwon, et al.
Publicado: (2020)

Multi-dimensional histone methylations for coordinated regulation of gene expression under hypoxia
por: Lee, Seongyeol, et al.
Publicado: (2017)

Hypoxic repression of CYP7A1 through a HIF-1α- and SHP-independent mechanism
por: Moon, Yunwon, et al.
Publicado: (2016)

Hypoxia-Driven HIF-1α Activation Reprograms Pre-Activated NK Cells towards Highly Potent Effector Phenotypes via ERK/STAT3 Pathways
por: Lim, Seon Ah, et al.
Publicado: (2021)

YAP-dependent Wnt5a induction in hypertrophic adipocytes restrains adiposity
por: Lee, Gwan-Jun, et al.
Publicado: (2022)

Wnt3a disrupts GR-TEAD4-PPARγ2 positive circuits and cytoskeletal rearrangement in a β-catenin-dependent manner during early adipogenesis
por: Park, Bongju, et al.
Publicado: (2019)

Hypoxia Induces PDK4 Gene Expression through Induction of the Orphan Nuclear Receptor ERRγ
por: Lee, Ja Hee, et al.
Publicado: (2012)

Efficacy of Magnesium Trihydrate of Ursodeoxycholic Acid and Chenodeoxycholic Acid for Gallstone Dissolution: A Prospective Multicenter Trial
por: Hyun, Jong Jin, et al.
Publicado: (2015)

Efficacy of Chenodeoxycholic Acid and Ursodeoxycholic Acid Treatments for Refractory Functional Dyspepsia
por: Jang, Sung Ill, et al.
Publicado: (2022)

Successful treatment of infantile oxysterol 7α-hydroxylase deficiency with oral chenodeoxycholic acid
por: Tang, Yun-Ping, et al.
Publicado: (2021)

RORα switches transcriptional mode of ERRγ that results in transcriptional repression of CYP2E1 under ethanol-exposure
por: Han, Yong-Hyun, et al.
Publicado: (2016)

Synergistic Inhibition of MRSA by Chenodeoxycholic Acid and Carbapenem Antibiotics
por: Cui, Kaiyu, et al.
Publicado: (2022)

Clioquinol as an inhibitor of JmjC-histone demethylase exhibits common and unique histone methylome and transcriptome between clioquinol and hypoxia
por: Moon, Yunwon, et al.
Publicado: (2022)

Developing a procedure to extract chenodeoxycholic acid and synthesize ursodeoxycholic acid from pig by-products
por: Kim, On You, et al.
Publicado: (2023)

Therapeutic Effect of Chenodeoxycholic Acid in an Experimental Rabbit Model of Osteoarthritis
por: Yan, Zhao-wei, et al.
Publicado: (2015)

Cerebrotendinous xanthomatosis‐associated diarrhea and response to chenodeoxycholic acid treatment
por: Brass, Eric P., et al.
Publicado: (2020)

Cerebrotendinous Xanthomatosis: diversity of presentation and refining treatment with chenodeoxycholic acid
por: Islam, Mahjabin, et al.
Publicado: (2021)

Chenodeoxycholic Acid-Amikacin Combination Enhances Eradication of Staphylococcus aureus
por: Cui, Kaiyu, et al.
Publicado: (2023)

Influence of the gut microbiota on endometriosis: Potential role of chenodeoxycholic acid and its derivatives
por: Li, Yangshuo, et al.
Publicado: (2022)

Direct Effect of Chenodeoxycholic Acid on Differentiation of Mouse Embryonic Stem Cells Cultured under Feeder-Free Culture Conditions
por: Park, Soon-Jung, et al.
Publicado: (2013)

Phospholipase D2 promotes degradation of hypoxia-inducible factor-1α independent of lipase activity
por: Park, Mi Hee, et al.
Publicado: (2015)

Gallstone Decalcification and Dissolution Using Chenodeoxycholate and Citrate
por: Sali, Avni, et al.
Publicado: (1990)

The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism
por: Chang, Soojeong, et al.
Publicado: (2019)

Hepatotoxicity due to chenodeoxycholic acid supplementation in an infant with cerebrotendinous xanthomatosis: implications for treatment
por: Huidekoper, Hidde H., et al.
Publicado: (2015)

Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis
por: Gong, Zizhen, et al.
Publicado: (2016)

Stra13/DEC1 and DEC2 inhibit sterol regulatory element binding protein-1c in a hypoxia-inducible factor-dependent mechanism
por: Choi, Su Mi, et al.
Publicado: (2008)

Comparison on Response and Dissolution Rates Between Ursodeoxycholic Acid Alone or in Combination With Chenodeoxycholic Acid for Gallstone Dissolution According to Stone Density on CT Scan: Strobe Compliant Observation Study
por: Lee, Jae Min, et al.
Publicado: (2015)

Fasting plasma chenodeoxycholic acid and cholic acid concentrations are inversely correlated with insulin sensitivity in adults
por: Cariou, Bertrand, et al.
Publicado: (2011)

Investigation of α,ω-Disubstituted Polyamine-Cholic Acid Conjugates Identifies Hyodeoxycholic and Chenodeoxycholic Scaffolds as Non-Toxic, Potent Antimicrobials
por: Sue, Kenneth, et al.
Publicado: (2023)

Suppression of Akt-HIF-1α signaling axis by diacetyl atractylodiol inhibits hypoxia-induced angiogenesis
por: Choi, Sik-Won, et al.
Publicado: (2016)

Evaluation of the effect of chenodeoxycholic acid treatment on skeletal system findings in patients with cerebrotendinous xanthomatosis
por: Zübarioğlu, Tanyel, et al.
Publicado: (2019)

Case Report: Early Treatment With Chenodeoxycholic Acid in Cerebrotendinous Xanthomatosis Presenting as Neonatal Cholestasis
por: Degrassi, Irene, et al.
Publicado: (2020)

Hypoxia Regulates the Expression of the Neuromedin B Receptor through a Mechanism Dependent on Hypoxia-Inducible Factor-1α
por: Park, Hyun-Joo, et al.
Publicado: (2013)

Pharmacy Compounded Medicines for Patients With Rare Diseases: Lessons Learned From Chenodeoxycholic Acid and Cholic Acid
por: Polak, Yasmin, et al.
Publicado: (2021)

Beta-lapachone inhibits pathological retinal neovascularization in oxygen-induced retinopathy via regulation of HIF-1α
por: Park, Sung Wook, et al.
Publicado: (2014)

High-spatial and colourimetric imaging of histone modifications in single senescent cells using plasmonic nanoprobes
por: An, Hyun Ji, et al.
Publicado: (2021)

Effect of dietary chenodeoxycholic acid on intestinal carcinogenesis induced by 1.2 dimethylhydrazine in mice and hamsters.
por: Martin, M. S., et al.
Publicado: (1981)

The safety and effectiveness of chenodeoxycholic acid treatment in patients with cerebrotendinous xanthomatosis: two retrospective cohort studies
por: Verrips, Aad, et al.
Publicado: (2019)

Chenodeoxycholic Acid Pharmacology in Biotechnology and Transplantable Pharmaceutical Applications for Tissue Delivery: An Acute Preclinical Study
por: Mooranian, Armin, et al.
Publicado: (2021)

Product development and quality of pharmacy compounded chenodeoxycholic acid capsules for Dutch cerebrotendinous xanthomatosis patients
por: Bouwhuis, Natalja, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4u9266deoht6g8hupmept0asb7